French registry to reveal how well kidney nerve procedure works for high blood pressure in daily practice

NCT ID NCT07206030

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This registry will follow 100 adults in France who undergo renal denervation (RDN) for high blood pressure. The procedure uses radiofrequency or ultrasound to calm overactive kidney nerves. Researchers will measure blood pressure changes at home and in the clinic over one year to see how well RDN works in real-world settings. The goal is to provide independent data to French health authorities on the procedure's value.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
renal denervation (a procedure using radiofrequency or ultrasound to disrupt kidney nerves)
What this could lead to
If successful, this registry could provide real-world evidence to support wider use of renal denervation as a safe and effective treatment for high blood pressure.
What could go wrong
This is an observational registry, not a controlled trial, so results may be influenced by patient selection or other factors. It does not test a new treatment but gathers routine care data.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION (HTN) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chu Grenoble Alpes

    RECRUITING

    La Tronche, France, 38700, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.